Search
Search Results
##search.searchResults.foundPlural##
-
-
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
155PDF: 153HTML: 11 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3694PDF: 1137HTML: 23368 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1430PDF: 830HTML: 1025 -
THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA Thalidomide ameliorates erythropoiesis and iron homeostasis
1455PDF: 1453PDF: 1035HTML: 227 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1265PDF: 875HTML: 261 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3461PDF: 1320HTML: 2300Fi.1 Gritti.Rambaldi: 221 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
974PDF: 535HTML: 218 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2879PDF: 1858HTML: 3766Pellagatti Fig 1: 233Pellagatti Fig. 2: 230 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2312PDF: 1005HTML: 4971 -
-
Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation Pidotimod in SARS-CoV-2 vaccination
1655PDF: 582HTML: 274 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3371PDF: 1274HTML: 2363 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4049PDF: 1075HTML: 3890Untitled: 184Cneo. Fig.1: 121Untitled: 113Untitled: 141Untitled: 146 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2896PDF: 1049HTML: 249Suppl. Files: 528 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2930PDF: 1125HTML: 126 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4252PDF: 1997HTML: 1945 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3364PDF: 739HTML: 755Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 198Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 200Table : Distribution of the sites of bleeding and their causes: 194 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2402PDF: 1208HTML: 281 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2189PDF: 740HTML: 2143Untitled: 235Untitled: 163Untitled: 188Untitled: 167Untitled: 182Untitled: 195Untitled: 196 -
EPIDEMIOLOGY OF MALARIA IN ENDEMIC AREAS
5419PDF: 2696HTML: 49722 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2939PDF: 985HTML: 7484







